Patents by Inventor Timothy Alan Gillespy

Timothy Alan Gillespy has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Thienopyrazoles
    Patent number: 7928231
    Abstract: Thienopyrazoles of formula I, their preparation, pharmaceutical compositions comprising these compounds, and their pharmaceutical uses in the treatment of disease states capable of being modulated by the inhibition of the protein kinases, in particular interleukin-2 inducible tyrosine kinase (ITK).
    Type: Grant
    Filed: March 26, 2009
    Date of Patent: April 19, 2011
    Assignee: Aventis Pharmaceuticals Inc.
    Inventors: John Gerard Jurcak, Matthieu Barrague, Timothy Alan Gillespy, Michael Louis Edwards, Kwon Yon Musick, Philip Marvin Weintraub, Yan Du, Ramalinga M. Dharanipragada, Ashfaq Ahmad Parkar
  • THIENOPYRAZOLES
    Publication number: 20100056514
    Abstract: Thienopyrazoles, their preparation, pharmaceutical compositions comprising these compounds, and their pharmaceutical uses in the treatment of disease states capable of being modulated by the inhibition of the protein kinases, in particular interleukin-2 inducible tyrosine kinase (ITK).
    Type: Application
    Filed: March 26, 2009
    Publication date: March 4, 2010
    Applicant: AVENTIS PHARMACEUTICALS INC.
    Inventors: John Gerard JURCAK, Matthieu BARRAGUE, Timothy Alan GILLESPY, Michael Louis EDWARDS, Kwon Yon MUSICK, Philip Marvin WEINTRAUB, Yan DU, Ramalinga M. DHARANIPRAGADA, Ashfaq Ahmad PARKAR
  • Thienopyrazoles
    Patent number: 7518000
    Abstract: Thienopyrazoles of formula I, their preparation, pharmaceutical compositions comprising these compounds, and their pharmaceutical uses in the treatment of disease states capable of being modulated by the inhibition of the protein kinases, in particular interleukin-2 inducible tyrosine kinase (ITK).
    Type: Grant
    Filed: March 6, 2006
    Date of Patent: April 14, 2009
    Assignee: Aventis Pharmaceuticals, Inc.
    Inventors: John Gerald Jurcak, Matthieu Barrague, Timothy Alan Gillespy, Michael Louis Edwards, Kwon Yon Musick, Phillip Marvin Weintraub, Yan Du, Ramalinga M. Dharanipragada, Ashfaq Ahmed Parkar
  • 2,6-SUBSTITUTED-4-MONOSUBSTITUTED AMINO-PYRIMIDINE AS PROSTAGLANDIN D2 RECEPTOR ANTAGONISTS
    Publication number: 20090036469
    Abstract: The present invention is directed to a compound of formula (I), wherein R1 and R2 are as defined herein, a pharmaceutical composition comprising a pharmaceutically effective amount of one or more compounds of the invention in admixture with a pharmaceutically acceptable carrier, and a method of treating a patient suffering from a PGD2-mediated disorder by administering to said patient a pharmaceutically effective amount of a compound of the invention.
    Type: Application
    Filed: October 7, 2008
    Publication date: February 5, 2009
    Applicant: SANOFI-AVENTIS
    Inventors: David STEFANY, Keith John HARRIS, Timothy Alan GILLESPY, Charles J. GARDNER, Joacy C. AGUIAR